2 terminated, 1 completed. 2 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Terminated 1 |
Follow EG-1962: new trials by email Literature Review of EG-1962 trials Research Report on EG-1962
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH EG-1962 (nimodipine microparticles), Enteral Nimodipine - Subarachnoid Hemorrhage, Aneurysmal | Phase 1 | Terminated | Edge Therapeutics Inc | 6 | 2016-09-01 | 2018-07-26 |
| Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage EG-1962 (nimodipine microparticles), Enteral Nimodipine - Subarachnoid Hemorrhage, Aneurysmal | Phase 3 | Terminated | Edge Therapeutics Inc | 374 | 2016-07-01 | 2018-07-26 |
| Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage Nimodipine, Nimodipine Microparticles - Ruptured Cerebral Aneurysm, Ruptured Berry Aneurysm | Phase 1 / Phase 2 | Completed | Edge Therapeutics Inc | 73 | 2013-09-01 | 2018-02-05 |
Subarachnoid Hemorrhage (3) · Aneurysm (1) · Aneurysm, Ruptured (1) · Rupture (1)
Canada (3) · United States (3) · Czechia (2) · Finland (2) · Australia (1) · Austria (1) · Germany (1) · Hong Kong (1) · Israel (1) · New Zealand (1) · Singapore (1)
R. Loch Macdonald, MD, PhD (2) · Daniel Hanggi (1)
PMID 25678453, PMID 27932607, PMID 30014184, PMID 31812149, PMID 32138631, PMID 32985652, PMID 37624739